Publications by authors named "KeeMing Chia"

Claim this Profile
T
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.
Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman, Elyssa Campbell, Kee-Ming Chia

Nat Struct Mol Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity.
Qian Du, Grady C Smith, Phuc Loi Luu, James M Ferguson, Nicola J Armstrong, Kee-Ming Chia, Chia-Ling Chan

Cell Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-canonical AR activity facilitates endocrine resistance in breast cancer.
KeeMing Chia, Heloisa Milioli, Neil Portman, Geraldine Laven-Law, Rhiannon Coulson

Endocr Relat Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel ATM-dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in melanoma.
Loredana Spoerri, Kelly Brooks, KeeMing Chia, Gavriel Grossman, Jonathan J Ellis

Pigment Cell Melanoma Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the androgen receptor in breast cancer.
KeeMing Chia, Megan O'Brien, Myles Brown, Elgene Lim

Curr Oncol Rep· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finally, how histone deacetylase inhibitors disrupt mitosis!
Brian Gabrielli, KeeMing Chia, Robyn Warrener

Cell Cycle· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone deacetylase inhibitor MGCD0103 has both deacetylase and microtubule inhibitory activity.
Keeming Chia, Heather Beamish, Kaneez Jafferi, Brian Gabrielli

Mol Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of histone deacetylase 3 produces mitotic defects independent of alterations in histone H3 lysine 9 acetylation and methylation.
Robyn Warrener, Keeming Chia, William D Warren, Kelly Brooks, Brian Gabrielli

Mol Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis